TNO Launches Innovative Digital Health Solutions in the Netherlands
Netherlands, Thursday, 13 March 2025.
TNO has unveiled new patient-centric digital health technologies designed to enhance personalized care and proactive health strategies in the Netherlands, promising improved healthcare outcomes through earlier, precise interventions.
Breakthrough in AI-Powered Drug Development
On March 3, 2025, TNO unveiled groundbreaking BERT-based classification models achieving remarkable accuracy rates between 0.91 and 0.97 in drug target assessment [1]. These innovative models, now available through the TargetTri platform, represent a significant advancement in analyzing therapeutic benefits and risks, with F1 scores ranging from 0.86 to 0.92 [1]. This development addresses a critical need in the pharmaceutical industry, where clinical success rates for drug candidates have historically remained at only 10-20% [1].
Strategic Alliance for Healthcare Innovation
In a significant move to accelerate healthcare innovation, TNO formed a strategic partnership with Techleap and Invest-NL on March 12, 2025 [2]. This collaboration aims to strengthen the Netherlands’ position in global healthcare technology, focusing particularly on compute innovations, quantum technology, and semiconductor developments [2]. The initiative comes at a crucial time, as Dutch startup growth has shown mixed results, with the scale-up ratio improving from 13% to 21.5% over five years, yet remaining below the European average of 23% [2].
Remote Health Monitoring Advancement
A significant milestone in digital health innovation occurred on March 11, 2025, with the appointment of Jildau Bouwman as professor of Remote Health Monitoring at Leiden University [3]. This appointment marks TNO’s commitment to developing digital solutions for enhanced home healthcare, emphasizing the integration of AI for personalized health advice based on individual genetics, environment, and medical history [3]. The initiative aligns with the principle of ‘Independently when possible, at home when possible, and digitally when possible’ [4].
Future Impact and Implementation
The innovations are set to transform healthcare delivery through a learning healthcare system that combines patient data with biological parameters [3]. TNO’s comprehensive approach includes collaboration with citizens, caregivers, and healthcare professionals to ensure effective data usage [3]. This patient-centric strategy is particularly timely as the Netherlands faces increasing healthcare challenges, with TNO’s recent projections indicating that between 6.6% and 7.6% of Dutch households may face healthcare accessibility issues in 2025 [5].
sources
- academic.oup.com
- siliconcanals.com
- www.staff.universiteitleiden.nl
- www.universiteitleiden.nl
- nl.linkedin.com